Newsletter
» Read newsletters
New bioactive film acting as an active principle reservoir for the integration... 
GRAVIT celebrates its 5th anniversary and 100th accompanied project!
On... 
ORGAR
RELIABLE RESPIRATORY SIGNALS FOR A SAFE STRATEGIC CLINICAL DECISION
In the context of a withdrawal decision for a patient in clinical difficulty, the ORGAR system developed by Pierre-Yves Guméry, researcher, and Laurent Heyer, resuscitator, will provide doctors with fundamental information based on observing the proper coordination of muscle activity in the whole respiratory system.» Description and functionalities
Non-invasive system for gathering and processing electromyographic signals on the overall inhalatory neuromuscular activity of the patient, via the surface» Technology
- EMG microsensors- Clinical model based on the rhythmic inhalatory activity of the muscles in the wings of the nose and the temporal structure of the inhalatory activity according to a rostro-caudal gradient.
» Performances
- Early diagnosis of recovery of normal respiration in the patient.- Reduction of intubation time and risks of complication under ventilation.
- Powerful software
» Target
Patients in withdrawal situations who present problems of vigilance» Application areas
- Resuscitation- Anaesthesia
» Laboratory
Techniques de l’Ingénierie Médicale et de la Complexité - Réf090502_Gumery_ORGAR2 _offre_29062010» Interview with Pierre-Yves Guméry and Laurent Heyer
What is the motivation for your research work?LH: As a resuscitator, I have had opportunities to observe that patients with vigilance problems presented difficulties in coordinating respiratory muscle activity. However this parameter was not taken into consideration in extubation decisions. There is a lack of expertise, probably because there is a problem with objectivity in decision-making. I had been looking for a long time to obtain robust EMG surface signal measurements that could be used in a clinical situation.
P-YG: For my part, as a signal processing specialist, I am concentrating on developing methods for extracting information from physiological signals which are difficult to interpret. Scientifically speaking, EMG signals have been used for a long time, but there is no method for using them in a clinical situation. I thought it would be interesting to rehabilitate them by using robustness strategies.
How could a company use your innovation?
P-YG: We are bringing technological innovation to a therapeutic strategy.
LH: From the industrial point of view, Orgar is a tool for exploring respiratory function and a tool that can be incorporated in a ventilator. The added value lies in the therapeutic direction provided. This is a tool for decision-taking and for monitoring and controlling the ventilator. For the moment, doctors involved in withdrawal place their trust in vigilance indicators that can often be persistent. As a diagnostic tool, ORGAR will enable time to be saved.
What is the status of your project?
We are in the clinical validation stage. A harmfulness investigation is in progress, aimed at showing that doctors who use information supplied by ORGAR are not harming their patients’ chances.
